Leonardo Pescitelli
Florence, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
Effectiveness of bimekizumab according to previous biologic exposure in patients with plaque psoriasis: a multicenter real-world study.
Journal: The Journal of dermatological treatment
Published: July 29, 2026
T2-Reg: a regional web registry on Th2-mediated diseases.
Journal: Italian journal of dermatology and venereology
Published: January 12, 2026
Therapeutic Modulation Of Peripheral Blood Cells And Inflammatory Indices During 52 Weeks Of Risankizumab In Responder Patients With Moderate-to-Severe Psoriasis: Results From A Multicenter Prospective Study.
Journal: Dermatology practical & conceptual
Published: August 31, 2025
Upadacitinib dose adjustment in moderate-to-severe atopic dermatitis: insights from a multicenter real-world study.
Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
Published: May 23, 2025
Risankizumab in very elderly patients in real-world practice.
Journal: Italian journal of dermatology and venereology
Published: November 07, 2024
A prospective Real-Life Multicenter Study of Tildrakizumab 200 mg in Patients with Moderate-Severe Psoriasis: Who is the Ideal Patient?
Journal: Dermatology practical & conceptual
Published: September 25, 2024
Long-term drug survival of risankizumab in psoriasis: insights from a real-life multicenter study on hard-to-treat areas.
Journal: Archives of dermatological research
Published: April 21, 2024
Efficacy of risankizumab after intra-class switching between anti IL-23 antagonists: a multi-center, retrospective, real-life observation.
Journal: Italian journal of dermatology and venereology
Published: November 24, 2023
Real-life effectiveness of Risankizumab according to body mass index: Results of an Italian multicentre retrospective study.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: January 24, 2023
Efficacy and Safety of Secukinumab in Elderly Patients with Moderate to Severe Plaque-Type Psoriasis: Post-Hoc Analysis of the SUPREME Study.
Journal: Clinical, cosmetic and investigational dermatology
Published: December 13, 2022
Tuscany consensus for the treatment of moderate-severe psoriasis: update and focus on practical guidelines for place in therapy of anti-IL-17 and anti-IL-23 biologics.
Journal: Italian journal of dermatology and venereology
Published: July 05, 2022
Hidradenitis Suppurativa in a Large Cohort of Italian Patients: Evaluation of the Burden of Disease.
Hidradenitis Suppurativa in a Large Cohort of Italian Patients: Evaluation of the Burden of Disease.
Journal: Dermatology (Basel, Switzerland)
Published: September 02, 2020
Last Updated: 09/26/2026